Hepatic and hematological complications following ecstasy usage

O. Shibolet; Y. Kalish; S. Gillis; Y. Ilan

Hepatic and hematological complications following ecstasy usage

O. Shibolet^*, Y. Kalish, S. Gillis, Y. Ilan

^*Corresponding author for this work

Hadassah University Medical Centre

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

"Ecstasy" (3,4-Methylenedioxymethamphetamine), is used as a mood enhancer. We describe a case of a 23 year-old male suffering from thrombotic thrombocytopenic purpura (TTP), and severe hepatitis following ingestion of ecstasy. We describe the various hepatic complications, including hepatitis, cirrhosis, and hepatic failure, in addition to the hematological complications including DIC and TTP secondary to ecstasy abuse. Ecstasy abuse should be considered in every patient with unexplained hepatic or hematologic complications.

Original language	English
Pages (from-to)	911-914, 991
Journal	Harefuah
Volume	140
Issue number	10
State	Published - Oct 2001
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{d5c42c67b74543dfb40493b3b205f93a,

title = "Hepatic and hematological complications following ecstasy usage",

abstract = "{"}Ecstasy{"} (3,4-Methylenedioxymethamphetamine), is used as a mood enhancer. We describe a case of a 23 year-old male suffering from thrombotic thrombocytopenic purpura (TTP), and severe hepatitis following ingestion of ecstasy. We describe the various hepatic complications, including hepatitis, cirrhosis, and hepatic failure, in addition to the hematological complications including DIC and TTP secondary to ecstasy abuse. Ecstasy abuse should be considered in every patient with unexplained hepatic or hematologic complications.",

author = "O. Shibolet and Y. Kalish and S. Gillis and Y. Ilan",

year = "2001",

month = oct,

language = "אנגלית",

volume = "140",

pages = "911--914, 991",

journal = "Harefuah",

issn = "0017-7768",

publisher = "Israel Medical Association",

number = "10",

}

TY - JOUR

T1 - Hepatic and hematological complications following ecstasy usage

AU - Shibolet, O.

AU - Kalish, Y.

AU - Gillis, S.

AU - Ilan, Y.

PY - 2001/10

Y1 - 2001/10

N2 - "Ecstasy" (3,4-Methylenedioxymethamphetamine), is used as a mood enhancer. We describe a case of a 23 year-old male suffering from thrombotic thrombocytopenic purpura (TTP), and severe hepatitis following ingestion of ecstasy. We describe the various hepatic complications, including hepatitis, cirrhosis, and hepatic failure, in addition to the hematological complications including DIC and TTP secondary to ecstasy abuse. Ecstasy abuse should be considered in every patient with unexplained hepatic or hematologic complications.

AB - "Ecstasy" (3,4-Methylenedioxymethamphetamine), is used as a mood enhancer. We describe a case of a 23 year-old male suffering from thrombotic thrombocytopenic purpura (TTP), and severe hepatitis following ingestion of ecstasy. We describe the various hepatic complications, including hepatitis, cirrhosis, and hepatic failure, in addition to the hematological complications including DIC and TTP secondary to ecstasy abuse. Ecstasy abuse should be considered in every patient with unexplained hepatic or hematologic complications.

UR - http://www.scopus.com/inward/record.url?scp=0035489963&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 11681122

AN - SCOPUS:0035489963

SN - 0017-7768

VL - 140

SP - 911-914, 991

JO - Harefuah

JF - Harefuah

IS - 10

ER -

Hepatic and hematological complications following ecstasy usage

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this